Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on March 30, 2016, reporting events as of March 29, 2016. The filing announces the consolidated financial results for the third quarter of fiscal year 2016 ended February 28, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been issued via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the reporting period is the third quarter of fiscal year 2016 ended February 28, 2016.
- Note that the press release information is not incorporated by reference into this filing.